Literature DB >> 10656236

Higher post-absorptive C-peptide levels in Type 1 diabetic patients without renal complications.

G Zerbini, R Mangili, L Luzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10656236     DOI： 10.1046/j.1464-5491.1999.00181.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN： 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  8 in total

1.  C-peptide is a bioactive peptide.

Authors:  J Wahren; K Ekberg; H Jörnvall
Journal:  Diabetologia       Date:  2007-01-18       Impact factor: 10.122

Review 2.  Pathological consequences of C-peptide deficiency in insulin-dependent diabetes mellitus.

Authors:  Ahmad Ghorbani; Reza Shafiee-Nick
Journal:  World J Diabetes       Date:  2015-02-15

3.  Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein.

Authors:  R S Mughal; J L Scragg; P Lister; P Warburton; K Riches; D J O'Regan; S G Ball; N A Turner; K E Porter
Journal:  Diabetologia       Date:  2010-05-12       Impact factor: 10.122

4.  C-peptide reduces high-glucose-induced apoptosis of endothelial cells and decreases NAD(P)H-oxidase reactive oxygen species generation in human aortic endothelial cells.

Authors:  V Cifarelli; X Geng; A Styche; R Lakomy; M Trucco; P Luppi
Journal:  Diabetologia       Date:  2011-07-20       Impact factor: 10.122

Review 5.  Physiological effects and therapeutic potential of proinsulin C-peptide.

Authors:  Gina L C Yosten; Christine Maric-Bilkan; Patrizia Luppi; John Wahren
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-09-23       Impact factor: 4.310

Review 6.  Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes.

Authors:  Karin Ekberg; Bo-Lennart Johansson
Journal:  Exp Diabetes Res       Date:  2008

7.  A C-peptide complex with albumin and Zn2+ increases measurable GLUT1 levels in membranes of human red blood cells.

Authors:  M Geiger; T Janes; H Keshavarz; S Summers; C Pinger; D Fletcher; K Zinn; M Tennakoon; A Karunarathne; D Spence
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

8.  Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds.

Authors:  Mirella Hansen de Almeida; Joana Rodrigues Dantas; Bianca Barone; Fabiano Marcel Serfaty; Rosane Kupfer; Marta Albernaz; Maria Rocio Bencke; Lenita Zajdenverg; Melanie Rodacki; José Egídio Paulo de Oliveira
Journal:  Clinics (Sao Paulo)       Date:  2013-01       Impact factor: 2.365
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.